National Safety Council Statement on the FDA Advisory Panel Approval of COVID-19 Vaccine and Employers' Subsequent Role

▴ National Safety Council Statement on the FDA Advisory Panel Approval of COVID-19 Vaccine and Employers' Subsequent Role
The National Safety Council applauds today's formal recommendation of the Pfizer COVID-19 vaccine and the CDC recommendations that prioritize distributing the vaccine first to healthcare personnel and long-term care facility residents, who need it most urgently.

The National Safety Council applauds today's formal recommendation of the Pfizer COVID-19 vaccine and the CDC recommendations that prioritize distributing the vaccine first to healthcare personnel and long-term care facility residents, who need it most urgently. The efforts of our healthcare workers have saved millions of lives over the last year. They must be first in line for vaccines.

Today's news is welcome, as the vaccine provides an additional layer of relief for a country undone by the pandemic. To the 157 million people in the U.S. workforce, employers play a critical role in helping the American public understand the details of implementation and the benefits a vaccine brings. NSC implores the business community to proactively lean into this new challenge with their support and voice. In addition, we urge the healthcare sector and government agencies to work with employers as a point of distribution.  That is where the employers' role begins – not where it ends. 

Experts project that at least 60-70% of the population needs immunity, through either vaccination or previous exposure, in order to end the pandemic. While vaccines for various illnesses tend to elicit strong feelings on both sides, widespread support for the COVID-19 vaccine is critical – not just to the health of our population. Our economic recovery depends on it.

The vaccine alone is not a panacea for the disease; however, it is a salve for millions of unemployed, hundreds of thousands of small businesses, and every organization and individual impacted by the financial fallout of the coronavirus. The pervasive adoption of the vaccine will help facilitate hiring, reopening, and a return to some level of business normalcy – understanding that the future world of work has been altered forever.

When the pandemic began, employers found themselves without standard guidance for responding to this pandemic. They deserve a roadmap for handling the vaccine. We urge the federal government to work with the business community – both the private and public sectors – to develop universal guidance for employers to roll out education and distribution of the vaccine to employees. NSC stands ready to assist with this effort. Then, each organization must take that guidance and create a vaccine plan and strategy that includes:

  • Employee education around the benefits of the vaccine and how to get it once it is widely available
  • Opportunities for employees to get the vaccine once it is available based on allocation criteria
  • Answers to questions about the legal rights of both employees and employers when it comes to requiring vaccines
  • A plan for augmenting operations in a post-vaccine world
  • An internal task force that will handle all vaccine-related issues for the company. This should be comprised of professionals from the HR, legal, health, and safety and communications departments.

It will take time for vaccines to be widely available. We cannot let our guard down. Employers must continue reinforcing proven COVID-19 safety precautions – encouraging face coverings, hand-washing, physical distancing, remote work for nonessential employees, testing, and contact tracing – to stop the spread.

As part of its SAFER effort, NSC has developed dozens of resources to help business leaders navigate the pandemic. NSC will continue to provide guidance for employers so they can safely and effectively implement vaccine strategies, and we will call on our vast network of partners – including those federal government agencies – to help us.

The approval of vaccines is groundbreaking. Worldwide strategies to distribute them should be just as innovative, with employers at the heart of the efforts.

About the National Safety Council
The National Safety Council is America's leading nonprofit safety advocate – and has been for over 100 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace, roadway, and impairment. We create a culture of safety to not only keep people safer at work but also beyond the workplace so they can live their fullest lives.

Tags : #NationalSafetyCouncil #FDA #COVID-19Vaccine #Pfizer #PfizerCOVID-19Vaccine #coronavirus #HealthcareWorkers #FightAgainstVirus #Covid19Updates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024